CHARGED ALPHATMFrontier AI stock research

MTLS · NasdaqGS

Materialise NV

Software - Application · Belgium

USD 7.770.8% daily changeQuote 2026-09-18 · USD
Market cap (USD)
US$448.67M
Trailing P/E
29.88x
Forward P/E
29.44x
Quarterly revenue growth
8.1%
Trailing net margin
4.8%
Indicated dividend yield

Snapshot 2026-09-20 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-10-28 (provider estimate, not issuer-confirmed).

Company background

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Company website

Q2 2026

Go beyond the headline.

Comparable businesses

MTLS peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

No suitable peers with fresh, comparable size data are available. We have not substituted unrelated companies.

Market metrics · missing or inapplicable values shown as —
MetricMTLSMaterialise NVSnapshot 2026-09-20Financial period: 2026-06-30
Market capMarket value, converted to USDUS$448.67M
Forward P/EProvider forward earnings estimate29.44x
EV / EBITDAEnterprise value / trailing EBITDA
Revenue growthLatest quarter vs prior-year quarter8.1%
Operating marginLatest reported quarter0.6%
Free cash flow yieldTrailing cash flow / market cap
Net debt / EBITDANet debt / trailing EBITDA-2.78x
Debt / equityTotal debt / positive book equity0.23x
Trailing P/ETrailing twelve-month earnings29.88x
Price / bookPrice / positive book equity per share1.54x
EV / salesEnterprise value / trailing revenue
Earnings growthLatest quarter vs prior-year quarter1,595.6%
Gross marginTrailing twelve months57.2%
Net marginTrailing twelve months4.8%
Return on equityProvider trailing return; positive equity only5.2%
Free cash flow marginTrailing free cash flow / revenue4.8%
Dividend yieldIndicated annual dividend / price
Earnings payoutProvider trailing dividend payout0.0%
Current ratioCurrent assets / current liabilities2.41x
BetaProvider historical market sensitivity1.36

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-20. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for MTLS

All available reporting periods
Q2 20262026-08-29

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.